💊 Médicaments A-Z 🧬 Cibles 🛠 Outils 📚 Guides
Tous les médicaments Classes de médicaments Aires thérapeutiques Effets Indésirables
Guides Glossaire Chronologie
Comparaisons Parcours des médicaments Familles de médicaments
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Bisoprolol

CHEMBL645 Phase 4 Approuvé Small molecule
Half-Life
10-12 hours
Bioavailability
—
Protein Binding
—
Molecular Weight
325.4 g/mol
LogP
1.9
Phase
4

A selective beta-1 adrenergic blocker used to treat high blood pressure, heart failure, and certain abnormal heart rhythms. By reducing the heart's workload and slowing the heart rate, it helps protect the heart over time. It is preferred over non-selective beta-blockers in patients with mild respiratory conditions.

Masse moléculaire

325,4470 g/mol

LogP

1,90

TPSA

60,00 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Cardiovascular Disease Chronic Obstructive Pulmonary Disease Chronic Kidney Disease Lymphoma Type 2 Diabetes Hypertension Breast Cancer Heart Failure Atrial Fibrillation Leukemia

Classes de médicaments

C — C - Cardiovascular System

Mécanisme d'action

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Pharmacokinetics (PK)

Half-Life 10-12 hours

Pharmacodynamics (PD)

Mécanisme

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Structure 2D

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1

                

                

                
                

                    
InChI

                    
InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3

                

                

                

                    
                    

                        
Molecular Formula

                        
C18H31NO4

                    

                    
                    

                        
HBD / HBA

                        
2 / 5

                    

                    
                    

                        
Liaisons Rotatives

                        
12

                    

                    
                    
                    

                        
Atomes Lourds

                        
23

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Foire aux questions

                

                    
                    

                        
                        

                            
A selective beta-1 adrenergic blocker used to treat high blood pressure, heart failure, and certain abnormal heart rhythms. By reducing the heart's workload and slowing the heart rate, it helps protect the heart over time. It is preferred over non-selective beta-blockers in patients with mild respiratory conditions.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

                        

                    

                    

                    
                    

                        
                        

                            
Key pharmacokinetic parameters for Bisoprolol: Half-life: 10-12 hours.

                        

                    

                    

                    

                        
                        

                            
Yes, Bisoprolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            
            

                
Related Drugs


                
                

                    
Same Drug Class

                    

                        
                        
                            Atorvastatin
                            Small molecule
                        
                        
                        
                            Amlodipine
                            Small molecule
                        
                        
                        
                            Lisinopril
                            Small molecule
                        
                        
                        
                            Metoprolol
                            Small molecule
                        
                        
                    

                

                

                
            

            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL645.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 2405.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.




        


        
        
    


    



    
Avertissement médical

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.